======================================================================
MODEL COMPARISON REPORT: BASELINE vs ENHANCED
======================================================================

OVERALL METRICS COMPARISON:
----------------------------------------------------------------------
Metric               | Baseline     | Enhanced     | Change      
----------------------------------------------------------------------
Accuracy             | 0.8680       | 0.8619       | -0.61%
Precision            | 0.8626       | 0.8594       | -0.32%
Recall               | 0.8620       | 0.8535       | -0.85%
F1 Score             | 0.8579       | 0.8521       | -0.58%


PER-CLASS F1-SCORE COMPARISON:
----------------------------------------------------------------------
Class           | Baseline     | Enhanced     | Change      
----------------------------------------------------------------------
glioma          | 0.8576       | 0.8220       | -3.56%
meningioma      | 0.7138       | 0.7572       | +4.35%
notumor         | 0.9222       | 0.9456       | +2.34%
pituitary       | 0.9382       | 0.8835       | -5.47%


KEY FINDINGS:
----------------------------------------------------------------------
Overall Verdict: NO IMPROVEMENT
Accuracy Improvement: -0.61%
F1-Score Improvement: -0.58%

Most Improved Class:
  meningioma: +4.35%

Least Improved Class:
  pituitary: -5.47%


RECOMMENDATIONS:
----------------------------------------------------------------------
- Model performance is good. Consider deploying the enhanced model.
- Baseline model performs similarly. Review training procedure.
